Andrew D. Goldberg - Director at Tarsus Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
TARS on Nasdaq
All Insider Reports
All Insider Reports

Andrew D. Goldberg - trading volume in the past year for Tarsus Pharmaceuticals, Inc.

Holdings reported by Andrew D. Goldberg for Tarsus Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 6.35K $174K $27.47 Jun 24, 2024 Direct
Stock Option (right to buy) 5K $55K $10.99 Jun 13, 2024 Direct Common Stock
Restricted Stock Units 0 $0 $27.47 Jun 24, 2024 Direct Common Stock

Transactions reported by Andrew D. Goldberg for Tarsus Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.